These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 502006)

  • 1. [Study on high molecular weight fibrinogen/fibrin complex (HMWFC) (author's transl)].
    Suzuki S; Matsui N
    Rinsho Ketsueki; 1979 Aug; 20(8):901-9. PubMed ID: 502006
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA; Diukov IV; Borodkin VV
    Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG; Brunswig D; Liehr H
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
    Wilmes EH; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of D2-E2 centers of interdomain binding of fibrin monomer during fibrinogen co-polymerization with an NH2-terminal disulfide knot of fibrin].
    Pozdniakova TM; Rybachuk VN; Ugarova TP
    Biokhimiia; 1987 Apr; 52(4):592-8. PubMed ID: 3593791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinetic movement of fibrin monomer (soluble fibrin monomer complex. S.F.M.C.) in cases of asphyxiated newborn (author's transl)].
    Suzuki S
    Rinsho Ketsueki; 1979 Jul; 20(7):740-4. PubMed ID: 501998
    [No Abstract]   [Full Text] [Related]  

  • 9. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 11. [alphaC domains of fibrinogen molecules as the structures accelerating fibrin assembly].
    Medved' LV; Gorkun OV; Maniakov VF; Belitser VA
    Mol Biol (Mosk); 1986; 20(2):461-70. PubMed ID: 3702870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of gabexate mesilate on measurement of coagulation and fibrinolysis. --The effect of high molecular weight Fbg/Fb complex in plasma-- (author's transl)].
    Suzuki S; Tahara C; Kazama M
    Rinsho Byori; 1981 Apr; 29(4):404-8. PubMed ID: 6798246
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical implications of analyses of fibrinogen and fibrin-derivatives in DIC].
    Magari Y; Ito M; Itoga T
    Rinsho Ketsueki; 1986 Oct; 27(10):1992-2007. PubMed ID: 3820619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of isolated fibrinogen degradation products in laboratory diagnosis].
    Fedorova ZD; Paradeeva IK; Zhukova IV; Elizarova AI; Pshenichnaia LP
    Probl Gematol Pereliv Krovi; 1979 May; 24(5):54-6. PubMed ID: 450898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of plasma fibrinogen and fibrin degradation products (FDP) in 100 normal persons and 32 cases of acute cerebrovascular disease (author's transl)].
    Wang GX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):8-10. PubMed ID: 7094732
    [No Abstract]   [Full Text] [Related]  

  • 18. [The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies (author's transl)].
    Kastendieck E; Barthels M
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):758-62. PubMed ID: 4437565
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.